tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Revenue

Compare
302 Followers

Immunome Revenue

Immunome had a revenue of 2.93M in the quarter ending Mar 31, 2025, with 6.87%. This bring the company's revenue in the last twelve months to 10.94M, Decreased 20.98%. In the fiscal year ending Dec 31, 2024, Immunome had annual revenue of 9.04M with -35.50% growth.
Revenue (ttm)
10.94M
Revenue Growth
-13.76%
P/S Ratio
91.33
Revenue/Employee
$69,015
Employees
131
Market Cap
$825.75M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
9.04M-4.98M-35.50%
Dec 31, 2023
14.02M+∞%
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis